Review





Similar Products

erythromycin ethylsuccinate  (Enamine Ltd)
99
Enamine Ltd erythromycin ethylsuccinate
Erythromycin Ethylsuccinate, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/Erythromycin+ethylsuccinate/custom%40en300-51033%4041379005
Average 99 stars, based on 1 article reviews
erythromycin ethylsuccinate - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
erythromycin  (MedChemExpress)
94
MedChemExpress erythromycin
(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and <t>erythromycin</t> (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.
Erythromycin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/Erythromycin/bio_rxiv__64898__2026__07__23__740263-120-12-13
Average 94 stars, based on 1 article reviews
erythromycin - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
erythromycin  (Thermo Fisher)
94
Thermo Fisher erythromycin
(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and <t>erythromycin</t> (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.
Erythromycin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/Erythromycin%2C+Cell+Culture+Grade/pm42353379-71-44-45
Average 94 stars, based on 1 article reviews
erythromycin - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
erythromycin eye ointment  (Guangzhou Baiyunshan)
86
Guangzhou Baiyunshan erythromycin eye ointment
(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and <t>erythromycin</t> (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.
Erythromycin Eye Ointment, supplied by Guangzhou Baiyunshan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/erythromycin+eye+ointment/pmc13015723-18-0-4
Average 86 stars, based on 1 article reviews
erythromycin eye ointment - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
cell culture grade  (Thermo Fisher)
94
Thermo Fisher cell culture grade
(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and <t>erythromycin</t> (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.
Cell Culture Grade, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/Erythromycin%2C+Cell+Culture+Grade/pm42262138-156-1-17
Average 94 stars, based on 1 article reviews
cell culture grade - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
erythromycin  (Pasteur Institute)
86
Pasteur Institute erythromycin
(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and <t>erythromycin</t> (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.
Erythromycin, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/erythromycin/pm42123536-197-5-12
Average 86 stars, based on 1 article reviews
erythromycin - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
erythromycin ery  (Macklin Inc)
86
Macklin Inc erythromycin ery
(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and <t>erythromycin</t> (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.
Erythromycin Ery, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erythromycin/ery+erythromycin/pm42128555-47-8-26
Average 86 stars, based on 1 article reviews
erythromycin ery - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


(A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and erythromycin (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.

Journal: bioRxiv

Article Title: Cortical organoids from congenital DM1 PSCs reveal MBNL-dependent corticogenesis defects and enable preclinical testing of therapeutic compounds

doi: 10.64898/2026.07.23.740263

Figure Lengend Snippet: (A) Scheme of the protocol used for organoids drug treatment. (B) RNA transcript levels of DMPK in 30-day-old organoids treated with or without tideglusib (TDG) and erythromycin (EM). (C) Representative images of RNA-FISH showing foci in 30-day-old CTL and CDM cortical organoids. (D) Quantification of DMPK foci number per cell by RNA FISH. (E-F) Representative images and quantification of EdU-labeled proliferating SOX2+ neural progenitor cells in control and CDM treated organoids. (G-H) Representative images and quantification of cleaved-caspase 3 staining in control, untreated and treated CDM organoids. (I) Western blot analysis showing protein level of GSK3β and RBM45 in control, untreated and treated CDM organoids. (J-K) Quantification of GSK3β and RBM45 levels as ratios to ACTB levels. Scale bars 50 µM. Colors indicate distinct cell lines within each genotype, and individual dots represent the mean value of three organoids from one independent differentiation experiment. Data are presented as mean ± SD. Statistical analysis was performed using one- way ANOVA followed by Dunnett’s multiple comparisons test. Statistical significance is indicated as follows: *p < 0.05; ***p < 0.001.

Article Snippet: Human cortical organoids were treated with 25μM tideglusib (Sigma Aldrich®) and 25μM erythromycin (MedChem Express®) starting from day 10 of differentiation until day 25.

Techniques: Labeling, Control, Staining, Western Blot